Intentional Warfarin Overdose

Therapeutic Drug Monitoring

Volumn 25, Issue 6, 2003, Pages 715-722

  Isbister, Geoffrey K ^a,b   Hackett, L Peter ^c   Whyte, Ian M ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b NEWCASTLE MATER HOSPITAL   (Australia)

^c Western Australian Centre for Pathology and Medical Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BRODIFACOUM; CHLORPROMAZINE; ENOXAPARIN; FRESH FROZEN PLASMA; HEPARIN; IPRATROPIUM BROMIDE; LOW MOLECULAR WEIGHT HEPARIN; NALOXONE; OXYCODONE; SALBUTAMOL; VITAMIN K GROUP; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; CASE REPORT; DRUG HALF LIFE; DRUG OVERDOSE; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; THROMBOSIS;

ADULT; ANTICOAGULANTS; HUMANS; MALE; OVERDOSE; WARFARIN;

EID: 0345060784     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200312000-00010     Document Type: Article

References (18)

1. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995;333: 11-17.
2. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 1996;348:423-428.
3. Crowther MA, Julian J, McCarty D, et al. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. Lancet. 2000; 356:1551-1553.
4. Hung A, Singh S, Tait RC. A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization. Br J Haematol. 2000;109:537-539.
5. Isbister GK, Dawson A, Isbister JP. Recommendations for the management of over-anticoagulation with warfarin. Emerg Med (Fremantle). 2001;13: 469-471.
6. Hackett LP, Ilett KF, Chester A. Plasma warfarin concentrations after a massive overdose. Med J Aust. 1985;142:642-643.
7. Bjornsson TD, Blaschke TF. Vitamin K1 disposition and therapy of warfarin overdose. Lancet. 1978;2: 846-847.
8. Toolis F, Robson RH, Critchley JA. (1981) Warfarin poisoning in patients with prosthetic heart valves. Br Med J. 1981;283:581-582.
9. Park BK, Scott AK, Wilson AC, et al. Plasma disposition of vitamin K1 in relation to anticoagulant poisoning. Br J Clin Pharmacol. 1984;18:655-662.
10. Bruno GR, Howland MA, McMeeking A, et al. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing. Ann Emerg Med. 2000;36:262-267.
11. Buckley NA, Whyte IM, Dawson AH, et al. Self-poisoning in Newcastle, 1987-1992. Med J Aust. 1995;162:190-193.
12. Whyte IM, Buckley NA, Dawson AH. Data collection in clinical toxicology: are there too many variables? J Toxicol Clin Toxicol. 2002;40:223-230.
13. Hylek EM, Chang YC, Skates SJ, et al. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med. 2000;160:1612-1617.
14. Cruickshank J, Ragg M, Eddey D. Warfarin toxicity in the emergency department: Recommendations for management. Emerg Med. 2001;13:91-97.
15. Breckenridge A, Orme M, Wesseling H, et al. Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man. Clin Pharmacol Ther. 1974;15:424-430.
16. Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 1998; 114:445S-469S.
17. Majerus PW, Tollefsen DM. (2001) Anticoagulant, Thrombolytic, and Antiplatelet Drugs. Goodman & Gillman's The Pharmacological Basis of Therapeutics (ed. by J. G. Hardman & L. E. Limbird), pp. 1519-1538. McGraw-Hill, New York.
18. Bosse GM, Mallory MN, Malone GJ. The safety of intravenously administered vitamin K. Vet Hum Toxicol. 2002;44:174-176.